{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:59:27Z","timestamp":1791601167473,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["19AA2007"],"award-info":[{"award-number":["19AA2007"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H30-Policy-Designated-004"],"award-info":[{"award-number":["H30-Policy-Designated-004"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology, Japan","doi-asserted-by":"crossref","award":["17H04141"],"award-info":[{"award-number":["17H04141"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although tranexamic acid is widely used in patients with haemoptysis, whether it improves mortality has not been well investigated. The aim of this study was to evaluate the effect of tranexamic acid on in-hospital mortality among patients with haemoptysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective study using data from the Japanese Diagnosis Procedure Combination inpatient database. We identified all cases of emergency admission due to haemoptysis from July 2010 to March 2017. Patients were divided into two groups: a control group, and a tranexamic acid group (those who received tranexamic acid on the day of admission). The primary outcome was in-hospital mortality, with secondary outcomes of hospital stay length and total healthcare cost. The data were evaluated using a propensity score matching analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 28,539 included patients, 17,049 patients received tranexamic acid and 11,490 patients did not. Propensity score analysis generated 9933 matched pairs. Compared to the control group, patients in the tranexamic acid group had significantly lower in-hospital mortality (11.5% vs. 9.0%; risk difference, \u2212\u20092.5%; 95% confidence interval (CI), \u2212\u20093.5 to \u2212\u20091.6%), shorter hospital stays (18\u2009\u00b1\u200924\u2009days vs. 16\u2009\u00b1\u200918\u2009days; risk difference, \u2212\u20092.4\u2009days; 95% CI, \u2212\u20093.1 to \u2212\u20091.8\u2009days), and lower total healthcare costs ($7573\u2009\u00b1\u200910,085 vs. $6757\u2009\u00b1\u20099127; risk difference, $\u2212\u2009816; 95% CI, $\u2212\u20091109 to \u2212\u2009523).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tranexamic acid may reduce in-hospital mortality among patients with haemoptysis requiring emergency admission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-019-2620-5","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T12:03:13Z","timestamp":1573041793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effect of tranexamic acid on mortality in patients with haemoptysis: a nationwide study"],"prefix":"10.1186","volume":"23","author":[{"given":"Takahiro","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8544-2569","authenticated-orcid":false,"given":"Hiroyuki","family":"Ohbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"2620_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000274492","volume":"80","author":"L Sakr","year":"2010","unstructured":"Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration. 2010;80:38\u201358.","journal-title":"Respiration."},{"key":"2620_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00134-002-1553-6","volume":"29","author":"TH Ong","year":"2003","unstructured":"Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med. 2003;29:317\u201320.","journal-title":"Intensive Care Med"},{"key":"2620_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1183\/09031936.00218214","volume":"46","author":"C Abdulmalak","year":"2015","unstructured":"Abdulmalak C, Cottenet J, Beltramo G, Georges M, Camus P, Bonniaud P, et al. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database. Eur Respir J. 2015;46:503\u201311.","journal-title":"Eur Respir J"},{"key":"2620_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005\u201332.","journal-title":"Drugs."},{"key":"2620_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1606424","volume":"376","author":"PS Myles","year":"2017","unstructured":"Myles PS, Smith JA, Forbes A, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136\u201348.","journal-title":"N Engl J Med"},{"key":"2620_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3054","volume":"344","author":"K Ker","year":"2012","unstructured":"Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.","journal-title":"BMJ."},{"key":"2620_CR7","volume":"3","author":"DA Henry","year":"2011","unstructured":"Henry DA, Carless PA, Moxey AJ, O\u2019Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;3:CD001886.","journal-title":"Cochrane Database Syst Rev"},{"key":"2620_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"CRASH-2 trial collaborators","year":"2010","unstructured":"CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23\u201332.","journal-title":"Lancet"},{"key":"2620_CR9","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","unstructured":"WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389:2105\u201316.","journal-title":"Lancet"},{"key":"2620_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","volume":"391","author":"A Gayet-Ageron","year":"2018","unstructured":"Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40\u2008138 bleeding patients. Lancet. 2018;391:125\u201332.","journal-title":"Lancet."},{"key":"2620_CR11","volume":"11","author":"G Prutsky","year":"2016","unstructured":"Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev. 2016;11:CD008711.","journal-title":"Cochrane Database Syst Rev"},{"key":"2620_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pupt.2016.07.006","volume":"40","author":"BL Bellam","year":"2016","unstructured":"Bellam BL, Dhibar DP, Suri V, Sharma N, Varma SC, Malhotra S, et al. Efficacy of tranexamic acid in haemoptysis: a randomized, controlled pilot study. Pulm Pharmacol Ther. 2016;40:80\u20133.","journal-title":"Pulm Pharmacol Ther"},{"key":"2620_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.chest.2018.09.026","volume":"154","author":"O Wand","year":"2018","unstructured":"Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial. Chest. 2018;154:1379\u201384.","journal-title":"Chest."},{"key":"2620_CR14","first-page":"129","volume":"42","author":"MS Fekri","year":"2017","unstructured":"Fekri MS, Hashemi-Bajgani SM, Shafahi A, Zarshenas R. Comparing adrenaline with tranexamic acid to control acute endobronchial bleeding: a randomized controlled trial. Iran J Med Sci. 2017;42:129\u201335.","journal-title":"Iran J Med Sci"},{"key":"2620_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7223\/apjdm.4.55","volume":"4","author":"S Matsuda","year":"2010","unstructured":"Matsuda S, Fujimori K, Fushimi K. Development of casemix based evaluation system in Japan. Asian Pacific J Dis Manag. 2010;4:55\u201366.","journal-title":"Asian Pacific J Dis Manag"},{"key":"2620_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476\u201382.","journal-title":"J Epidemiol"},{"key":"2620_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002736","volume":"3","author":"K Shigematsu","year":"2013","unstructured":"Shigematsu K, Nakano H, Watanabe Y. The eye response test alone is sufficient to predict stroke outcome--reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013;3:e002736.","journal-title":"BMJ Open"},{"key":"2620_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"key":"2620_CR19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1213\/ANE.0000000000002724","volume":"127","author":"A Jerath","year":"2018","unstructured":"Jerath A, Yang QJ, Pang KS, Looby N, Reyes-Garces N, Vasiljevic T, et al. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen. Anesth Analg. 2018;127:1323\u201332.","journal-title":"Anesth Analg"},{"key":"2620_CR20","doi-asserted-by":"publisher","first-page":"e637","DOI":"10.1097\/PCC.0000000000001724","volume":"19","author":"T Maeda","year":"2018","unstructured":"Maeda T, Michihata N, Sasabuchi Y, Matsui H, Ohnishi Y, Miyata S, et al. Safety of tranexamic acid during pediatric trauma: a nationwide database study. Pediatr Crit Care Med. 2018;19:e637\u201342.","journal-title":"Pediatr Crit Care Med"},{"key":"2620_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.7326\/0003-4819-152-6-201003160-00010","volume":"152","author":"ME Griswold","year":"2010","unstructured":"Griswold ME, Localio AR, Mulrow C. Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias. Ann Intern Med. 2010;152:393\u20135.","journal-title":"Ann Intern Med"},{"key":"2620_CR22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","volume":"39","author":"PR Rosenbaum","year":"1985","unstructured":"Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33\u20138.","journal-title":"Am Stat"},{"key":"2620_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1214\/09-STS313","volume":"25","author":"EA Stuart","year":"2010","unstructured":"Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25:1\u201321.","journal-title":"Stat Sci"},{"key":"2620_CR24","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28:3083\u2013107.","journal-title":"Stat Med"},{"key":"2620_CR25","volume-title":"PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing","author":"E Leuven","year":"2003","unstructured":"Leuven E, Sianesi B. PSMATCH2: Stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Boston: Boston College Department of Economics; 2003."},{"key":"2620_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/aje\/kwk020","volume":"165","author":"DL Miglioretti","year":"2007","unstructured":"Miglioretti DL, Heagerty PJ. Marginal modeling of nonnested multilevel data using standard software. Am J Epidemiol. 2007;165:453\u201363.","journal-title":"Am J Epidemiol"},{"key":"2620_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","volume":"73","author":"KY Liang","year":"1986","unstructured":"Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13\u201322.","journal-title":"Biometrika"},{"key":"2620_CR28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","volume":"11","author":"JM Robins","year":"2000","unstructured":"Robins JM, Hern\u00e1n MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550\u201360.","journal-title":"Epidemiology."},{"key":"2620_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res. 2011;46:399\u2013424.","journal-title":"Multivariate Behav Res"},{"key":"2620_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1242\/jcs.110.2.139","volume":"110","author":"EG Levin","year":"1997","unstructured":"Levin EG, Santell L, Osborn KG. The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location. J Cell Sci. 1997;110:139\u201348.","journal-title":"J Cell Sci"},{"key":"2620_CR31","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","volume":"377","author":"CRASH-2 trial collaborators","year":"2011","unstructured":"CRASH-2 trial collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377:1096\u2013101.","journal-title":"Lancet"},{"key":"2620_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018987","volume":"6","author":"C Guerriero","year":"2011","unstructured":"Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. CRASH 2 trial collaborators. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One. 2011;6:e18987.","journal-title":"PLoS One"},{"key":"2620_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000331501","volume":"83","author":"M Fartoukh","year":"2012","unstructured":"Fartoukh M, Khoshnood B, Parrot A, Khalil A, Carette MF, Stoclin A, et al. Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis. Respiration. 2012;83:106\u201314.","journal-title":"Respiration."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2620-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2620-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T06:41:09Z","timestamp":1721976069000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2620-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2620"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2620-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]},"assertion":[{"value":"16 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the University of Tokyo. The board waived the need for informed consent, as this was a retrospective study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Institutional Review Board waived the requirement for informed consent because of the anonymous nature of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}